An interventional study of Polarcare Machine and Standard of care ice therapy in Carpal Tunnel Syndrome and Perioperative/Postoperative Complications, sponsored by University of Chicago. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-05.
Sponsored by University of Chicago · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 97 studies in Carpal Tunnel Syndrome with a site in United States — 10 open to participants now, 12 under way, none of them phase 3. Carpal Tunnel Syndrome · United States.
Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, this one is the 10th largest by planned enrollment of the 72 interventional ones that give a count, is one of 2 that started in 2023, is one of 47 with no phase, reaches primary completion later than 4 of the 11 other live ones, and was the 86th registered.
591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
Browse Carpal Tunnel Syndrome studies →10 of the 97 studies in Carpal Tunnel Syndrome with a site in United States are open now. Recruiting first, the newest first:
New York Institute of Technology · Sites in United States
Ages 18+
University of Nevada, Las Vegas · Sites in United States
Ages 18+
University of Arizona · Sites in United States
Ages 18+
Extremity Medical · Sites in United States
Ages 18–85
Spaulding Rehabilitation Hospital · Sites in United States
Ages 18–80
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
97 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 11 · Phase 3 2 · Phase 4 10
First in 1997; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 128 is above the median of 60 across 446 interventional studies indexed under Carpal Tunnel Syndrome.
Median enrollment 50 across the 72 interventional studies, 107 across the 24 observational. Of the 68 that completed or were terminated, 16 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 97 have an industry lead sponsor. The 10 most frequent:
University of Chicago is the lead sponsor of 926 studies on the registry; 187 are open to participants now.
Of its 103 completed or terminated interventional studies of FDA-regulated products, 72 (70%) have results posted.
University of Chicago has 1 study filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
4 of the studies in Carpal Tunnel Syndrome with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04804293Mayo ClinicAssessment of Carpal Tunnel Syndrome by Shearwave Elastography | 2026-12-20 |
| NCT07158892University of Texas at AustinUnderstanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | 2027-01-20 |
| NCT06907849University of Tennessee Graduate School of Medicine124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome | 2027-03 |
| NCT04206215Spaulding Rehabilitation HospitalNoninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome | 2027-07-02 |
Add all 4 to your calendar (.ics) → With an account.
Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study seeks to perform an appropriately-powered study to evaluate any clinical difference between continuous cooling therapy and traditional ice for treatment of post-operative pain in open CTR surgery.
Post-operative pain control is paramount to all operative procedures and involves several modalities. Both pharmaceutical and non-pharmaceutical measures are frequently used. Carpal tunnel release (CTR) surgery is one of the most common surgeries performed in the U.S. with over 400,000 procedures per year.2 Frequently, ice is used as a treatment modality following surgical CTR.3 Several products have been developed in the past decades to improve ice therapy in the rehabilitation period. One such product is the Polar Care which provides up to 6-8 hours of continuous icing.
While there is good data supporting the use of cooling therapy (ice) for post-operative pain, there is lack of data surrounding the use of continuous cooling therapy machines such as the PolarCare following carpal tunnel release (CTR). The two papers that evaluated the efficacy of continuous cooling therapy following CTR had conflicting results on any added benefit of continuous cooling therapy over traditional icing.
There is no standard of care for post-operative icing at UCMC following CTR. Clinicians currently decide whether to give patients a PolarCare machine on the day of surgery without any algorithm. All other patients are encouraged to use traditional icing methods. This study seeks to perform an appropriately-powered study to evaluate any clinical difference between continuous cooling therapy and traditional ice for treatment of post-operative pain in open CTR surgery.
The investigators hypothesize that participants receiving continuous cooling therapy will have a statistically significantly lower pain score compared to those receiving traditional ice therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Postoperative care with experimental ice therapy
Other: Polarcare Machine
Postoperative care with standard of care ice therapy
Other: Standard of care ice therapy
Use of Polar Care ice machine as often as possible, but a minimum of three 15 minute uses per day, for the first 3 days after surgery. No single use should last longer than 30 minutes.
Use of commercial reusable ice packs as often as possible, but a minimum of three 15 minute uses per day, for the first 3 days after surgery. No single use should last longer than 30 minutes.
Visual Analog Scale (VAS) for pain
The visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. A patient marks a point on the line that matches the amount of pain he or she feels.
Time frame: 3 days
Disabilities of the Arm, Shoulder, and Hand questionnaire
he DASH is a 30-item self-report questionnaire designed to assess musculoskeletal disorders of the upper limbs.
Time frame: 1 week
Plan to share: No — IPD will not be shared with other researchers
No publications or documents are linked to this record.
Started Jun 2023 (actual). Primary completion is estimated for Sep 2026, 39 months after the start.
Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 39 months is above that.
Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.